3Lunel FM, Mennink-Kersten MA, Ruegebrink D, et al. Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy [ J ]. Diagn Microbiol Infect Dis, 2009, 64 (4) : 408415. 被引量：1
4Pitarch A, Abian J, Carrascal M, et al. Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies [ J ]. Proteomics, 2004, 4(10): 3084-3106. 被引量：1
5Pitarch A, Diez-Orejas R, Molero G, et al. Analysis of the serologic response to systemic Candida albicans infection in a murine model [ J]. Proteomics, 2001, 1 (4) : 550-559. 被引量：1
7Thomasl DP, Viudes A, Monteagudo C, et al. A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis [J]. Proteomics, 2006, 6(22) : 6033-6041. 被引量：1
8Karageorgopoulos DE, Voulumanou EK, Ntziora F, et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis [J]. Clin Infect Dis, 2011, 52(6) : 750-770. 被引量：1
9Racil Z, Kocmanova I, Lengerova M, et al. Difficulties in using 1,3- β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis [ J ]. J Med Microbiol, 2010, 59(9) : 1016-1022. 被引量：1
10Mohr JF, Sims C, Paetznick V, et al. Prospective survey of ( 1,3 ) -β- D-glucan and its relationship to invasive candidiasis in the surgical in- tensive care unit setting[ J ]. J Clin Microbiol, 2011,49 (1) : 58-61. 被引量：1
